Dexamethasone induced cardiac hypertrophy in newborn rats is accompanied by changes in myosin heavy chain phenotype and gene transcription

Molecular and Cellular Biochemistry

Volumn 209, Issue 1-2, 2000, Pages 165-174

  Muangmingsuk, Sunthorn ^a   Ingram, Paul ^a   Gupta, Mahesh P ^b   Arcilla, Rene A ^a   Gupta, Madhu ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Heart Institute for Children   (United States)

Author keywords

Dexamethasone; Gene expression; Hypertrophy; Myosin heavy chain; Promoter function

Indexed keywords

DEXAMETHASONE; MYOSIN HEAVY CHAIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; GENE EXPRESSION; GENE SEQUENCE; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PHENOTYPE; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; RAT; TRANSCRIPTION REGULATION;

ANIMALS; ANIMALS, NEWBORN; CARDIOMEGALY; DEXAMETHASONE; GENE EXPRESSION REGULATION; HEART; MYOCARDIUM; MYOSIN HEAVY CHAINS; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION, GENETIC;

EID: 0033921939     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007128300430     Document Type: Article

References (46)

1. Cummings JJ, D'Eugenio DB, Gross SJ: A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. New Engl J Med 320: 1504-1510, 1989
2. Werner JC, Sicard RE, Hansen WR, Solomon E, Cowett RM, Oh W: Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia. J Pediatr 120: 286-291, 1992
3. Bensky AS, Kothadia JM, Covitz W: Cardiac effect of dexamethasone in very low birth weight infants. Pediatrics 97: 818-821, 1996
4. Ohning BL, Fyfe DA, Riedel PA: Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia. Am Heart J 125: 253-258, 1993
5. Haney I, Lachance C, van Doesburg NH, Fouron JC: Reversible steroid-induced hypertrophic cardiomyopathy with left ventricular outflow tract obstruction in two newborns. Am J Perinatology 12: 271-274, 1995
6. Torres A, Belser WW III, Umeda PK, Tucker D: Indicators of delayed maturation of rat heart treated prenatally with dexamethasone. Ped Res 42: 139-144, 1997
7. Bian X, Briggs MM, Schachat FH, Seidler FJ, Slotkin TA: Glucocorticoids accelerated the ontogenetic transition of cardiac ventricular myosin heavy-chain isoform expression in the rat: Promotion by prenatal exposure to a low dose of dexamethasone. J Dev Phys 18: 35-42, 1992
8. Sicard RE, Werner JC: Dexamethasone induces a transient relative cardiomegaly in neonatal rats. Ped Res 31: 359-363, 1992
9. Kurowski TT, Czerwinski SM: Glucocorticoid modulation of cardiac mass and protein. Med Sci Sports Exer 22: 312-315, 1990
10. Sicard RE, Werner JC: Biochemical correlates of dexamethasone-induced relative cardiomegaly in neonatal rats. In vivo 9: 75-80, 1995
11. Clark AF, DeMartino GN, Wildenthal K: Effects of glucocorticoid treatment on cardiac protein synthesis and degradation. Am J Physiol 250: C821-C827, 1986
12. Gupta M, Gupta MP, Arcilla RA, Zak R: Cardiomyocytes and non-muscle cells in cardiac hypertrophy: A molecular perspective. Prog Ped Cardiol 9: 183-197, 1999
13. 1-adrenergic agonist and activated protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem 269: 3775-3782, 1994
14. Gupta MP, Gupta M, Zak R: An E-Box/M-CAT motif and cognate binding proteins regulate the basal muscle specific and cAMP inducible expression of rat cardiac a-myosin heavy chain gene. J Biol Chem 269: 29677-29687, 1994
15. Izumo S, Nadal-Ginard B, Mahdavi V: All members of the myosin heavy chain multigene family respond to thyroid hormone in a highly tissue-specific manner. Science 231: 597-600, 1986
16. Chizzonite RA, Zak R: Regulation of myosin isoenzyme composition in fetal and neonatal rat ventricle by endogenous thyroid hormones. J Biol Chem 259: 12628-12632, 1984
17. Izumo S, Lompre AM, Matsuoka R et al.: Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. J Clin Invest 79: 970-977, 1987
18. Holubarsch CH, Goulette RP, Litten RZ, Martin BJ, Mulieri LA, Alpert NR: The economy of force development. Myosin isozyme pattern and myofibrillar ATPase activity in normal and hypertrophied rat myocardium. Circ Res 56: 78-86, 1985
19. Jones WK, Grupp IL, Doetschman T, Grupp G, Osinaska H, Hewett TE, Biovin G, Gulick J, Ng WA, Robbins J: Ablation of the murine α-myosin heavy chain gene leads to dosage effects and functional deficits in the heart. J Clin Invest 98: 1906-1917, 1996
20. Lowes BD, Minobe W, Abraham WT et al.: Changes in gene expression in the intact human heart: Down regulation of α-myosin heavy chain in hypertrophied failing myocardium. J Clin Invest 100: 2315-2324, 1997
21. Nakao K, Minobe W, Roden R, Bristow RM, Leindand LA: Myosin heavy chain gene expression in the human heart failure. J Clin Invest 100: 2362-2370, 1997
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with folin phenol reagent. J Biol Chem 193: 265-275, 1951
23. Chirgwin JM, Prizybyla AE, McDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979
24. Clark WA, Chizzonite RA, Everett AW, Rabinowitz M, Zak R: Species correlation between cardiac isomyosins: A comparison of electrophoretic and immunological properties. J Biol Chem 257: 5449-5454, 1982
25. Gupta MP, Gupta M, Zak R, Sukhatme VP: Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha myosin heavy chain gene. J Biol Chem 266: 12813-12816, 1991
26. Gupta M, Zak R, Libermann TA, Gupta MP: Tissue-restricted expression of the cardiac α-myosin heavy chain gene is controlled by a downstream repressor element containing a palindrome of two Ets-binding sites. Mol Cell Biol 18: 7243-7258, 1998
27. Chen CA, Okayama H. Calcium phosphate-mediated gene transfer: A highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6: 632-638, 1988
28. Rosenthal N: Identification of regulatory elements of cloned genes with transcriptional assays. Meth Enzymol 152: 704-720, 1987
29. Miyabo S, Yanagisawa KI, Ooya E, Hisada T, Kishida S: Ontogeny of circadian corticosterone rhythm in female rats: Effects of periodic maternal deprivation and food restriction. Endocrinology 106: 636-642, 1980
30. Clark AF, Tandler B, Vignos PJ: Glucocorticoid-induced alterations in the rabbit heart. Lab Invest 47: 603-610, 1982
31. Hicks DC, Lee A, Kilgore BS et al.: Glucocorticoid effects on embryonic chick heart. Ann Clin Lab Sci 12: 477-483, 1982
32. Griffin EE, Wildenthal K: Regulation of cardiac protein balance by hydrocortisone: interaction with insulin. Am J Physiol 234: E306-E313, 1978
33. Levinovitz A, Norstedt G: Developmental and steroid hormonal regulation of insulin-like growth factor II expression. Mol Endocrinol 3: 797-803, 1989
34. Brem AS, Bina RB, Klinger JR, King T, Werner JC: Glucocorticoid metabolism in the newborn heart. Proc Soc Exp Biol Med 209: 146-151, 1995
35. Calovini T, Haase H, Morano I: Steroid-hormone regulation of myosin subunit expression in smooth and cardiac muscle. J Cell Biochem 59: 69-78, 1995
36. Sheer D, Morkin E: Myosin isoenzyme expression in rat ventricle: Effects of thyroid hormone analogs, catecholamine, glucocorticoids and high carbohydrate diet. J Pharmacol Exp Ther 220: 872-878, 1984
37. Schaible TF, Malhotra A, Ciambrone G, Scheuer J: The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circ Res 54: 38-49, 1984
38. Scheuer J, Malhotra A, Schaible TF, Capasso J: The effects of gonadectomy and hormonal replacement on rat hearts. Circ Res 61: 12-19, 1987
39. Czerwinski SM, Kurowski TT, McKee EE, Zak R, Hickson RC: Myosin heavy chain turnover during cardiac mass changes by glucocorticoids. J Appl Physiol 70: 300-305, 1991
40. Bruna RD, Ries S, Himmelstoss C, Kurtz A: Expression of cardiac angiotensin receptor genes in rat hearts is regulated by steroids but not by angiotensin II. J Hypertens 13: 763-769, 1995
41. Danberg J, Grekin RJ: Corticoid regulation of atrial natriuretic factor secretion and gene expression. Am J Physiol 263: H1377-H1381, 1992
42. Oikarinen A, Makela J, Vuorio T, Vuorio E: Comparison of collagen gene expression in the developing chick embryo tendon and heart. Tissue and development time-dependent action of dexamethasone. Biochem Biophys Acta 1089: 40-46, 1991
43. Argentin S, Sun YL, Lihrmann I, Schmidt TJ, Drouin J, Nemer M: Distal cis-acting promoter sequences mediate glucocorticoid stimulation of cardiac natriuretic factor gene transcription. J Biol Chem 266: 23315-23322, 1991
44. Parrelli JM, Meisler N, Cutroneo KR: Identification of glucocorticoid response element in the human transforming growth factor beta 1 gene promoter. Int J Biochem Cell Biol 30: 623-627, 1998
45. Subramaniam N, Carins W, Okret S: Glucocorticoids repress transcription from a negative response element recognized two homeodomain-containing proteins, pbx and Oct-1. J Biol Chem 273: 23567-23574, 1998
46. Petz LN, Nardulli AM, Horwitz KB, Freedman LP, Shapiro DJ: DNA binding is induced by binding of the glucocorticoid receptor DNA binding domain and progestrone receptors to their response element. J Ster Biochem Mol Biol 60: 31-41, 1997